Managed Health Care

Centene

Centene released FY2026 Q1 earnings on April 28 Pre-Market EST, actual revenue USD 45.06 B (forecast USD 47.55 B), actual EPS USD 3.11 (forecast USD 1.785)

Cangxi Ge's EPS for Q1 is $3.11

Centene to Release FY2026 Q1 Earnings on April 28 Pre-Market EST, Forecast Revenue USD 47.55 B, EPS USD 1.785

Kangxicuo's Q1 2026 Financial Report Expected Analysis

Centene released FY2025 Q4 earnings on February 6 Pre-Market (EST), actual revenue USD 45.09 B (forecast USD 48.35 B), actual EPS USD -2.2399 (forecast USD -1.5219)

Centene released FY2025 Annual Earnings on February 6 Pre-Market (EST), Actual Revenue USD 176.15 B (Forecast USD 192.67 B), Actual EPS USD -13.5343 (Forecast USD -12.272)

Conseg Predicts 2026 Profits to Exceed Wall Street Expectations

Centene to Release FY2025 Q4 Earnings on February 6, 2026, Pre-Market EST; Forecast Revenue USD 48.41 B, EPS USD -1.5219

Rockefeller Capital Management Significantly Increased Holdings in Concho Resources

Centene released FY2025 Q3 earnings on October 29 Pre-Market (EST), actual revenue USD 45.35 B (forecast USD 47.83 B), actual EPS USD -13.5012 (forecast USD -0.3934)

Centene released FY2025 9 Months earnings on October 29 Pre-Market (EST), actual revenue USD 135.41 B, actual EPS USD -11.3913

Conxico Reports Unexpected Profit in Q3, Beats Estimates

Kongsixgo Reports Q3 Net Income of -6.631 Billion USD

Centene to Release FY2025 Q3 Earnings on October 29, Pre-Market EST; Forecast Revenue USD 47.83B, EPS USD -0.3934

Welikes Recommends Healthcare Stocks Centene Gets a Buy Rating

Cantor Fitzgerald Downgrades Conexon Group to Neutral

Centene released FY2025 Q2 earnings on July 25 Pre-Market (EST), actual revenue USD 42.46 B (forecast USD 44.2 B), actual EPS USD -0.5126 (forecast USD 0.2987)

Centene released FY2025 Semi-Annual earnings on July 25 Pre-Market (EST), actual revenue USD 85.34 B, actual EPS USD 2.1378

Sunrun shares down despite upgrade, Kangxige hits new lows due to earnings concerns

Centene to Release FY2025 Q2 Earnings on July 25, Pre-Market EST; Forecast Revenue USD 44.29 B, EPS USD 0.1224

OPTIMI HEALTH CORP

HCW Biologics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

Silexion Therapeutics

Micware

GCL Global

MetaVia

EMMIS ACQUISITION CORP. ORD USD0.0001 (S/R 12/09/2030)

HORIZON SPACE ACQUISITION II CORP COM USD0.0001 30/03/2026(SUB/RIGHTS)

Bristol-Myers Squibb Company

Centene Corporation (CNC.US) Fourth Quarter and Full Year 2025 Earnings Conference Call

Centene Corporation (CNC.US) Q2 2025 Earnings Conference Call

RBRK

CHRW

Top Wall Street analysts upgraded several companies, including SM Energy, Rubrik Inc, CH Robinson Worldwide Inc, Elevance Health Inc, and Centene Corp. Notably, CH Robinson was upgraded from Hold to Buy with a new price target of $200. Other upgrades included SM Energy to $55, Rubrik to $85, Elevance Health to $498, and Centene to $80.

benzinga_article

Rubrik

C.H. Robinson Worldwide

Elevance Health

SM Energy

This CH Robinson Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

ETSY

Wall Street analysts have made several upgrades and downgrades, with Centene and ETSY receiving upgrades to Buy. Stock futures are trading higher despite recent declines, as concerns about rising yields and inflation persist. The 30-year Treasury yield has reached its highest level since 2007. Major indices closed lower, with the Russell 2000 down 1.01%. Oil prices fell slightly, while gold and silver also declined due to a stronger dollar and rising yields. The cryptocurrency market faced pressure from institutional selling.

Franco-Neveda

Cigna

Humana

Crown Castle

BJs Wholesale Club

Ovintiv

X-Energy

Here are Wednesday’s top Wall Street analyst research calls: BJ’s Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and more

NCLH

The S&P 500 closed lower on Tuesday due to inflation concerns and increased rate hike expectations. The healthcare sector outperformed, with stocks like Humana and Centene leading gains, as investors shifted towards defensive stocks. Conversely, the consumer discretionary sector suffered the most, impacted by a 3.8% rise in the Consumer Price Index, leading to declines in stocks such as Tesla and Norwegian Cruise Line.

- The S&P 500 (SPX) declined on Tuesday due to an inflation update from the Bureau of Labor Statistics and increased rate hike expectations.  
- The healthcare sector was the top performer as investors shifted towards defensive stocks, while the consumer discretionary sector experienced significant losses due to a rise in the Consumer Price Index, which reached 3.8% annually.  
- Notable stocks in the healthcare sector included Humana and Centene, while consumer discretionary stocks like Tesla and Norwegian Cruise Line saw declines amid rising inflation concerns.

Tip Ranks

Norwegian Cruise

Tesla

Health Care Select Sector SPDR

Leverage Shares 2X Long TSLA Daily ETF

SPDR S&P Health

Direxion Daily TSLA Bull 2X Shares

Direxion Daily TSLA Bear 1X Shares

VG Health

GraniteShares 2x Long TSLA Daily ETF

T-Rex 2X Long Tesla Daily Target ETF

T-Rex 2X Inverse Tesla Daily Target ETF

AXS TSLA Bear Daily ETF

iShares US Healthcare Providers

S&P 500

Invesco QQQ Trust

Zimmer Biomet

Steris

Stryker

Carvana

Carnival

Garmin

Carnival plc

Top Stock Gainers Today, 5/12/26

Coordinated Care and Seattle Seahawks Host Youth Mental Health Summit | CNC Stock News

StockTitan

Coordinated Care and Seattle Seahawks Host Youth Mental Health Summit | CNC Stock News

Fidelis Care has awarded $140,000 in behavioral health grants to eight organizations in New York State to support innovative solutions for individuals with substance use disorders. The grants aim to reduce barriers to care, focusing on underserved populations. Recipients include Friends of Recovery, La Casa de Salud, and Wellcome Care Medical, among others. The funding will enhance outreach, screening, and coordinated care to improve access to treatment and support long-term recovery. Fidelis Care emphasizes the importance of community-driven solutions in addressing mental health and substance use challenges.

prnewswire

09:41 ETFidelis Care Awards $140,000 in 2026 Here for Your Health Behavioral Health Grants

PODD

SBIO

LABD

Insulet Corp. (PODD) shares rose 6.03% to $160.40 on a weak trading day for the market, with the S&P 500 down 0.38% and the Dow Jones down 0.63%. This increase ended a three-day losing streak, although the stock remains 54.80% below its 52-week high of $354.88. Insulet outperformed competitors like Eli Lilly, which fell 1.22%, and Johnson & Johnson, which dropped 0.94%. Trading volume reached 2.8 million, surpassing the 50-day average of 1.1 million.

MarketWatch Automated

Insulet

ALPS Medical Breakthrough

Direxion S&P Biotech Bear 3X

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

First Trust NYSE Arca Biotech Index Fd

Direxion S&P Biotech Bull 3X

SPDR S&P Biotech

iShares US Medical Devices

SPDR S&P Health Equip

iShares Biotechnology ETF

Dow Jones Industrial Average

Eli Lilly

DexCom

Johnson & Johnson

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Centene Corp. (CNC) shares rose 4.44% to $55.33 on a strong trading day, outperforming competitors like HCA Healthcare and IQVIA Holdings. The S&P 500 Index increased by 1.46%, while the Dow Jones Industrial Average rose by 1.24%. Despite the gain, Centene's stock remains 13.75% below its 52-week high of $64.15. Trading volume reached 8.0 million, surpassing the 50-day average of 6.7 million.

Centene(CNC.US)

This CH Robinson Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

Here are Wednesday’s top Wall Street analyst research calls: BJ’s Wholesale Club, Centene, Cigna, Crown Castle, ETSY, Franco-Nevada, Humana, Ovintiv, X-Energy, and more

Top Stock Gainers Today, 5/12/26

Coordinated Care and Seattle Seahawks Host Youth Mental Health Summit | CNC Stock News

09:41 ETFidelis Care Awards $140,000 in 2026 Here for Your Health Behavioral Health Grants

Insulet Corp. Stock Outperforms Competitors On Strong Trading Day

Centene Corp. Stock Outperforms Competitors On Strong Trading Day

Is Wall Street Bullish or Bearish on Centene Stock?